Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial
Main Authors: | Maisel, Alan S., Mueller, Christian, Fitzgerald, Robert, Brikhan, Robert, Hiestand, Brian C., Iqbal, Navaid, Clopton, Paul, van Veldhuisen, Dirk J. |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143832/ |
Similar Items
-
The role of urine neutrophil gelatinase – associated lipocalin (NGAL) in acute heart failure in patients with ST – elevation myocardial infarction
by: Kirbiš, Simona, et al.
Published: (2015) -
Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study
by: Macdonald, Stephen, et al.
Published: (2012) -
Acute Decompensated Heart Failure Update
by: Teerlink, John R, et al.
Published: (2015) -
Cardiorenal biomarkers in acute heart failure
by: Choudhary, Rajiv, et al.
Published: (2012) -
Considerations for initial therapy in the treatment of acute heart failure
by: Peacock, William F., et al.
Published: (2015)